YUNNAN BAIYAO(SZ:000538)2025-07-10 09:12Financial Performance - In Q1 2025, the company achieved a revenue of 10.841 billion CNY, a year-on-year increase of 0.62% [2] - The net profit attributable to shareholders was 1.935 billion CNY, up 13.67% year-on-year [2] - The basic earnings per share reached 1.08 CNY, reflecting a growth of 13.66% [2] - The net cash flow from operating activities was 714 million CNY, showing a significant increase of 35.39% [2] - The weighted average return on equity was 4.86%, an increase of 0.68 percentage points year-on-year [2] - The company had cash and cash equivalents of 11.062 billion CNY and total assets of 54.253 billion CNY [2] Pharmaceutical Business Group - In 2024, the pharmaceutical business group reported a main business revenue of 6.924 billion CNY, a year-on-year growth of 11.8% [3] - The sales revenue of the core product, Yunnan Baiyao aerosol, exceeded 2.1 billion CNY, with a growth rate of over 26% [3] - Other significant products, such as Yunnan Baiyao plaster and capsules, also saw substantial revenue growth [4] - The sales revenue of Pudilan anti-inflammatory tablets reached nearly 200 million CNY, with a year-on-year increase of over 22% [4] Health Products Business Group - The health products business group aims to establish itself as a benchmark for new concepts in Chinese health living [5] - The group plans to enhance its oral care business while expanding into professional markets and hotel services [5] - There is a focus on increasing the scale of hair care products and expanding into skin management [5] Distribution Channels - The health products segment has a well-established national sales team, maintaining a leading market share in oral care products [6] - The company is optimizing its distribution channels, strengthening traditional offline advantages while exploring new retail formats [6] - This channel strategy significantly enhances the company's market competitiveness and supports new product commercialization [7] Dividend Distribution - For the 2024 fiscal year, the company plans to distribute a cash dividend of 11.85 CNY per 10 shares, totaling approximately 2.164 billion CNY [8] - The total cash dividend for 2024, including a special dividend, amounts to 23.98 CNY per 10 shares, totaling approximately 4.279 billion CNY, which represents 90.09% of the net profit attributable to shareholders [8]